drug · small molecule
patient view →surufatinib
Phase 2updated 2mo agoby $HCM HUTCHMED (China) Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and 26 investigational indications.
targets
Fibroblast growth factor receptor 1Vascular endothelial growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that